Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Keymed Biosciences (2162 HK)
Watchlist
65
Analysis
Health Care
•
Hong Kong
Keymed Biosciences Inc. operates a biotechnology company. The Company focus on the in-house discovery and development of innovative biological therapies. Keymed Biosciences provides services in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Keymed Biosciences
•
28 Feb 2023 08:55
Keymed Biosciences (2162.HK) - The $1.2B Deal with AstraZeneca for ADC and the Logic Behind
It’s wise decision for Keymed to out-license CMG901 and receive cashflow in advance due to uncertainties.Biotech has to rely on Big Pharma in post...
Xinyao (Criss) Wang
Follow
204 Views
Share
bearish
•
Thematic (Sector/Industry)
•
26 Feb 2023 09:13
China Healthcare Weekly (Feb.24) - No. 1 Central Document, 8th National VBP, TCM Formula Granules
China unveiled "No. 1 central document" to enhance the development of rural medical market. The 8th national VBP is coming. Pfizer is under heavy...
Xinyao (Criss) Wang
Follow
345 Views
Share
bullish
•
Keymed Biosciences
•
21 Feb 2023 08:55
Keymed Biosciences (2162.HK) - We Have High Hopes for Keymed, but Valuation Is Expensive
Keymed is pragmatic in R&D/commercialization, which set it apart from other biotech. We have high hopes for Keymed due to Chen Bo and his...
Xinyao (Criss) Wang
Follow
355 Views
Share
bullish
•
Thematic (Sector/Industry)
•
11 Dec 2022 09:01
China Healthcare Weekly (Dec.9) - COVID Policy Update, Biotech Growth Curve, HKEX Chapter 18A Review
China further optimized COVID policy, so as to release risks in advance and recover ASAP. The growth curve of biotech is not linear. We reviewed...
Xinyao (Criss) Wang
Follow
346 Views
Share
bullish
•
Quantitative Analysis
•
30 Oct 2022 10:03
Hong Kong Connect Flows (Oct 28th): Tencent, Meituan, Wuxi Biologics, Kuaishou
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Tencent, Meituan, Wuxi Biologics, Kuaishou.
Ke Yan, CFA, FRM
Follow
253 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x